The 30,000-square foot facility — a collaborative effort by Johnson & Johnson Innovation, New York State and New York Genome Center — will have capacity for up to 30 life science startups focused on biotech, pharmaceutical, medical devices and consumer health.
Johnson & Johnson Innovation LLC, New York State and the New York Genome Center are working together to launch a new JLABS in New York City. Called JLABS @ NYC, the 30,000-square-foot facility will be located at the New York Genome Center (NYGC) in SoHo and will open in 2018. The project, which will receive $17 million in New York State funding, will have capacity for up to 30 life science startups focused on biotech, pharmaceutical, medical devices and consumer health.
“The ever-evolving life science sector is discovering solutions to the most pressing problems of our time, helping to cure disease and save lives around the world,” said Governor Mario Cuomo. “New York is poised to be a global leader in this industry, and the new, vital incubator JLABS will be the catalyst that pushes our state into the forefront of this exciting field. I look forward to working with Johnson & Johnson and the New York Genome Center to build momentum in the life science industry and establish New York as the home of discoveries that will drive the economy and create a better future for all.”Read Complete Article